![](https://webarchive.library.unt.edu/eot2008/20090513131326im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090513131326im_/http://www.cancer.gov/images/spacer.gif)
The following are newly-released NCI research funding opportunities:
Molecular Approaches to Diet and Pancreatic Cancer Prevention
PA-05-040
Application Receipt Dates: May 10, Sept. 10, 2005; Jan. 10, May 10, Sept. 10, 2006; Jan. 10, May 10, Sept. 10, 2007
This funding opportunity will use the NIH investigator-initiated research project grants (R01) award mechanism.
For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2520 or contact Dr. Sharon Ross at rosssha@mail.nih.gov.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) to Improve the Chemistry and Targeted Delivery of RNAi Molecules
PA-05-041
Application Receipt Dates: May 10, Sept. 10, 2005; Jan. 10, May 10, Sept. 10, 2006; Jan. 10, May 10, Sept. 10, 2007
This funding opportunity will use the STTR (R41/R42) and SBIR (R43/R44) grant mechanism(s).
For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2521 or contact Dr. Suresh K. Arya at aryas@exchange.nih.gov.
For comprehensive information about NCI funding priorities and opportunities,
go to http://www.cancer.gov/researchandfunding.
The NIH Roadmap provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. For information on Roadmap funding opportunities, go to http://nihroadmap.nih.gov.
|